Company Statement: Special committee of Genentech board of directors responds to Roche's announced intention to commence a tender offer
****************************************South San Francisco, Calif. -- 30 January 2009 -- The special committee of the Board of Directors of Genentech, Inc. (NYSE: DNA) today urged shareholders to take no action at this...To view the full article, register now.
Already a subscriber? Click here to view full article